GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
61.26
+5.11 (9.10%)
At close: Oct 26, 2026, 4:00 PM EDT
61.75
+0.49 (0.80%)
After-hours: Oct 26, 2026, 6:12 PM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,300 employees as of December 31, 2025. The number of employees increased by 300 or 30.00% compared to the previous year. That makes GeneDx Holdings the 13,040th largest employer in the world and 2,017th in the United States.
Employees
1,300
Change (1Y)
300
Growth (1Y)
30.00%
Revenue / Employee
$349,558
Profits / Employee
-$81,813
Market Cap
1.83B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,300 | 300 | 30.00% |
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Mar 31, 2021 | 985 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 1,002 |
| CareDx | 765 |
| Veracyte | 755 |
| Adaptive Biotechnologies | 624 |
WGS News
- 3 days ago - GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026 - Business Wire
- 6 days ago - GeneDx enhances genome testing portfolio with long-read whole-genome sequencing - TheFly
- 6 days ago - GeneDx announces plans to enhance genome testing portfolio with lrWGS - TheFly
- 6 days ago - GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis - Business Wire
- 7 days ago - GeneDx advances clinical adoption of genomic medicine with 27 abstracts at ASHG - TheFly
- 7 days ago - GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026 - Business Wire
- 19 days ago - GeneDx presents new findings on genomic newborn screening at ICoNS 2026 - TheFly
- 19 days ago - GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026 - Business Wire